Mineralys Therapeutics, Inc. MLYS
Regular-session close
After hours · Nov 20, 4:01 PM ET
- YTD
- -62.36%
- 1 year
- -67.38%
Held by funds
111 US ETFs and mutual funds hold MLYS · largest positions
- VTI 0.00% of fund $30.20M
- FSPHX 0.43% of fund $29.65M
- NJM 0.04% of fund $28.10M
- ANOIX 0.47% of fund $24.20M
- IWM 0.03% of fund $22.51M
- ANOGX 0.36% of fund $21.38M
- XBI 0.21% of fund $20.86M
- FSSNX 0.05% of fund $16.14M
- FHCIX 0.45% of fund $15.08M
- VXF 0.01% of fund $13.76M
- FBTTX 0.45% of fund $10.57M
- NLO 0.07% of fund $9.87M
- FIDGX 0.11% of fund $9.72M
- IWO 0.06% of fund $8.16M
- FSMAX 0.02% of fund $7.77M
- FBIOX 0.12% of fund $6.91M
- VEXRX 0.03% of fund $6.69M
- IBB 0.06% of fund $6.69M
- VTWO 0.04% of fund $6.56M
- FESM 0.08% of fund $5.03M
Ownership
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Catalys Pacific, LLC | 8.81% | 7,799,518 | 106.54M | Sep 29, 2026 |
| RA Capital Management, L.P. | 8.69% | 7,692,750 | 105.08M | Sep 29, 2026 |
| Blackrock Inc. | 6.97% | 6,172,153 | 84.31M | Sep 29, 2026 |
| Samsara BioCapital, LLC | 6.63% | 5,871,018 | 80.20M | Sep 29, 2026 |
| FMR, LLC | 5.32% | 4,713,195 | 64.38M | Sep 29, 2026 |
| Deerfield Management Company, L.P | 4.47% | 3,958,000 | 54.07M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SmallCap World Fund Inc | 2.83% | 2,502,854 | 34.19M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 2.22% | 1,968,124 | 26.88M | Jun 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 1.79% | 1,584,493 | 21.64M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 1.66% | 1,468,689 | 20.06M | Sep 29, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.33% | 1,180,000 | 16.12M | Sep 29, 2026 |
| American Century Mutual Funds, Inc.-Small Cap Growth Fund | 1.09% | 962,999 | 13.15M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Leadership team
Who runs MLYS, and what each was last paid
Jon Congleton, President, Chief Executive Officer & DirectorAverage age 53
| Name | Title | Pay | Age |
|---|---|---|---|
| Jon Congleton | President, Chief Executive Officer & Director | $1.11M | 63 |
| James J. Ferguson FACC | Chief Medical Officer | $882K | 72 |
| Adam Scott Levy | Chief Financial Officer & Secretary | $880K | 48 |
| Brian Taylor Slingsby | Founder & Executive Director | $78.0K | 49 |
| Danielle Mahoney | Senior Vice President of Quality Assurance | — | — |
| Eric J. Warren | Chief Commercial Officer | — | 54 |
| Jeffrey A. Munsie | Chief Legal Officer & Secretary | — | 49 |
| Jose Breton | Senior Vice President of Finance & Controller | — | 37 |
| Michael Tortorici | Senior Vice President of Translational Medicine | — | — |
| Robert McKean | Senior Vice President of CMC | — | — |
| Jessica Ibbitson | Executive Vice President of Operations | — | — |
Pay is the latest total FMP has for each person (salary, bonus, stock and other awards) and can lag the newest proxy statement. Source: Financial Modeling Prep, from the company’s SEC filings.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| AKKARAJU SRINIVAS | Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Feb 18, 2026 | 5,877,220 |
| CONGLETON JON | Chief Executive Officer | Sale | Jul 12, 2026 | 603,621 |
| FERGUSON JAMES J. III | Officer | Stock Award(Grant) | Aug 9, 2026 | 102,400 |
| KARYDAS DAPHNE | Director | Conversion of Exercise of derivative security | Sep 14, 2026 | 6,200 |
| LEVY ADAM SCOTT | Chief Financial Officer | Stock Award(Grant) | Feb 18, 2026 | 48,538 |
| RA CAPITAL MANAGEMENT, L.P. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Mar 29, 2026 | 0 |
